Evidence map›Paper›PMID 36710255›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Membrane Targeted Azobenzene Drives Optical Modulation of Bacterial Membrane Potential.

Tailise Carolina de Souza-Guerreiro, Gaia Bondelli, Iago Grobas, Stefano Donini, Valentina Sesti, Chiara Bertarelli, Guglielmo Lanzani, Munehiro Asally, Giuseppe Maria Paternò

Open access · goldFull text read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Illuminating the dark majority: photobiology of nonphotosynthetic bacteria.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Membrane Targeted Azobenzene Drives Optical Modulation of Bacterial Membrane Potential.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  19. Bacteria associated with glioma: a next wave in cancer treatment.Frontiers in cellular and infection microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Tailise Carolina de Souza-GuerreiroSchool of Life Sciences, University of Warwick, Coventry, CV4 7AL, UK.ORCID 0000-0002-7223-1284
Gaia BondelliCenter for Nanoscience and Technology, Istituto Italiano di Teconologia, Milano, 20133, Italy.
Iago GrobasPhysical and Theoretical Chemistry Laboratory, Oxford, OX1 3QZ, UK.ORCID 0000-0003-3609-8081
Stefano DoniniCenter for Nanoscience and Technology, Istituto Italiano di Teconologia, Milano, 20133, Italy.
Valentina SestiDepartment of Chemistry, Materials and Chemical Engineering "Giulio Natta" Politecnico di Milano, Milano, 20133, Italy.
Chiara BertarelliDepartment of Chemistry, Materials and Chemical Engineering "Giulio Natta" Politecnico di Milano, Milano, 20133, Italy.
Guglielmo LanzaniCenter for Nanoscience and Technology, Istituto Italiano di Teconologia, Milano, 20133, Italy.
Munehiro AsallySchool of Life Sciences, University of Warwick, Coventry, CV4 7AL, UK.ORCID 0000-0002-8273-7617
Giuseppe Maria PaternòCenter for Nanoscience and Technology, Istituto Italiano di Teconologia, Milano, 20133, Italy.ORCID 0000-0003-2349-566X
Center for Nano Science and Technology · ITPolitecnico di Milano · ITUniversity of Warwick · GBUniversity of Oxford · GB

Funding

Biotechnology and Biological Sciences Research CouncilEngineering and Physical Sciences Research CouncilFondazione Cariplo 2018-0979MRC Doctoral Training Partnership MR/N014294/1Warwick Integrative Synthetic Biology Centre BB/M017982/1
6 · The paper itself

Abstract

Recent studies have shown that bacterial membrane potential is dynamic and plays signaling roles. Yet, little is still known about the mechanisms of membrane potential dynamics regulation-owing to a scarcity of appropriate research tools. Optical modulation of bacterial membrane potential could fill this gap and provide a new approach for studying and controlling bacterial physiology and electrical signaling. Here, the authors show that a membrane-targeted azobenzene (Ziapin2) can be used to photo-modulate the membrane potential in cells of the Gram-positive bacterium Bacillus subtilis. It is found that upon exposure to blue-green light (λ = 470 nm), isomerization of Ziapin2 in the bacteria membrane induces hyperpolarization of the potential. To investigate the origin of this phenomenon, ion-channel-deletion strains and ion channel blockers are examined. The authors found that in presence of the chloride channel blocker idanyloxyacetic acid-94 (IAA-94) or in absence of KtrAB potassium transporter, the hyperpolarization response is attenuated. These results reveal that the Ziapin2 isomerization can induce ion channel opening in the bacterial membrane and suggest that Ziapin2 can be used for studying and controlling bacterial electrical signaling. This new optical tool could contribute to better understand various microbial phenomena, such as biofilm electric signaling and antimicrobial resistance.

Indexed as

Azo CompoundsPotassiumBacteriaMembrane PotentialsazobenzeneAzo CompoundsPotassiumbacterial cell electrophysiologybacterial electrical signalingbioelectricitynanomaterialsoptostimulationphotonics

Identifiers

PMID36710255
PMCPMC10015841
OpenAlexW4318542587

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read42
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.